FLAG-IDA FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA: A SINGLE CENTRE 5-YEAR STUDY

被引：0
|
作者：
Agbuduwe, C. [1 ]
Follows, G. [1 ]
Craig, J. [1 ]
Uttenthal, B. [1 ]
Crawley, C. [1 ]
Krishnamurthy, P. [1 ]
机构：
[1] Cambridge Univ Hosp NHS Trust, Haematol, Cambridge, England
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E938
引用
收藏
页码：385 / 385
页数：1
相关论文
共 50 条
  • [41] A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial
    Russell, Nigel H.
    Hills, Robert K.
    Kjeldsen, Lars
    Clark, Richard E.
    Ali, Sahra
    Cahalin, Paul
    Thomas, Ian F.
    Burnett, Alan K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (03) : 528 - 534
  • [42] FLAG/FLAG-Ida Regimen in Secondary and Relapsed/Refractory Acute Myeloid Leukemia-Even in the Era of New Treatment Modalities Still a Significant Player
    Doma, Sasa Anzej
    Sever, Matjaz
    Jakos, Gorazd
    Podgornik, Helena
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [43] FLAG-lite regimen is effective bridging salvage chemotherapy for relapsed/refractory acute myeloid Leukaemia - a single centre experience
    Mehra, V.
    Raj, K.
    Potter, V.
    Mclornan, D.
    de lavallade, H.
    Hayden, J.
    Ong, G.
    Cave, D.
    Kulasekararaj, A.
    Pagliuca, T.
    Mufti, G. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 137 - 137
  • [44] TREATMENT WITH FLAG-IDA OR FLAGO-IDA REGIMEN IN ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA. RETROSPECTIVE ANALYSIS OF THE PETHEMA AML REGISTRY
    Burgues, J.
    Montesinos, P.
    Martinez-Cuadron, D.
    Serrano, J.
    Fernandez, P.
    Rayon, C.
    Sayas, M.
    Barrios, M.
    Perez, C.
    Herrera, P.
    Martinez, M.
    Garcia, R.
    Gayoso, J.
    Perez-Encinas, M.
    Riaza, R.
    Prieto, J.
    Colorado, M.
    Amador, M.
    Moscardo, F.
    Sanz, M.
    HAEMATOLOGICA, 2013, 98 : 25 - 25
  • [45] FLAG-IDA REGIMEN AS SALVAGE THERAPY IN REFRACTORY/RELAPSED AML PATIENTS: A SINGLE-CENTER EXPERIENCE
    Delia, M.
    Pastore, D.
    Carluccio, P.
    Pasciolla, C.
    Bitetti, C.
    Franco, A.
    Anelli, L.
    Mestice, A.
    Albano, F.
    Specchia, G.
    HAEMATOLOGICA, 2016, 101 : 383 - 383
  • [46] FLAG-IDA Regimen as Bridge Therapy to Allotransplant in Refractory/Relapsed AML Patients: A Single Center Experience
    Delia, M.
    Pastore, D.
    Carluccio, P.
    Pasciolla, C.
    Ricco, A.
    Rossi, A. Russo
    Mestice, A.
    Albano, F.
    Specchia, G.
    ANNALS OF HEMATOLOGY, 2017, 96 : S83 - S83
  • [47] FLAG-(IDA)-Mylotarg in the therapy of relapsed and refractory acute myeloid leukemia.
    Fabbiano, F
    Mondello, F
    Magrin, S
    Felice, R
    Marino, C
    Turri, D
    Mirto, S
    BLOOD, 2005, 106 (11) : 236B - 236B
  • [48] TREATMENT OF ACUTE MYELOID LEUKEMIA IN OLDERS WITH AN OUTPATIENT FLAG-IDA PROTOCOL
    Gallarreta, Z. Diez
    Vazquez, G. Perez
    Montes-Gaisan, C.
    Bermudez, A.
    Cuesta, A.
    Yanez, L.
    Lopez-Duarte, M.
    Colorado, M.
    Insunza, A.
    Gutierrez, M.
    Sanroma, P.
    Conde, E.
    Baro, J.
    Richard, C.
    Iriondo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 274 - 274
  • [49] FLAG-IDA Has Significant Activity As Frontline Induction or Salvage Therapy for Patients with High Risk and/or Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Bhella, Sita D.
    Atenafu, Eshetu G.
    Schuh, Andre C.
    Minden, Mark D.
    Schimmer, Aaron D.
    Gupta, Vikas
    Seftel, Matthew D.
    Alam, Naheed
    Lutynski, Andrzej
    Rostom, Amr
    Rydlewski, Anna
    Yee, Karen
    BLOOD, 2014, 124 (21)
  • [50] FLAG-IDA plus venetoclax in newly diagnosed (ND) or relapsed/refractory (RR) AML
    Jen, Wei Ying
    Takahashi, Koichi
    Loghavi, Sanam
    Kadia, Tapan M.
    Daver, Naval Guastad
    Xiao, Lianchun
    Short, Nicholas James
    Borthakur, Gautam
    Issa, Ghayas C.
    Pemmaraju, Naveen
    Reville, Patrick Kevin
    Bravo, Guillermo Montalban
    Yilmaz, Musa
    Garcia-Manero, Guillermo
    Ravandi-Kashani, Farhad
    Konopleva, Marina
    Mullin, Jillian K.
    Pierce, Sherry
    Kantarjian, Hagop M.
    Dinardo, Courtney Denton
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345